Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Adenosylmethionine Metabolism in Human Inflammation

6 sierpnia 2015 zaktualizowane przez: En-Pei Isabel Chiang, National Chung Hsing University

Translational Study on the Regulation of Adenosylmethionine Synthesis During Chronic Inflammation

The investigators propose to conduct a translational study on the regulation of S-adenosylmethionine synthesis and cellular methylation reactions during chronic inflammation. Development of in vitro cell models may reveal the regulatory mechanisms by which specific inflammatory mediators cause metabolic changes and alter DNA methylation status. Metabolic and pharmacological studies in the in vivo models will enable us to better understand the regulation of inter-organ homeostasis of S-adenosyl methionine and help identify tissue specific biomarkers for methylation and epigenetic modifications in different stage of chronic inflammation. The clinical study in human subjects will help distinguish the impacts of autoimmune rheumatic disease, degenerated joint disease, or specific medication use on significant clinical and biochemical markers in folate and vitamin B6 metabolic pathways.The Investigators hope the present study can identify specific clinical markers for potential epigenetic changes in patients suffering from chronic inflammation, which will contribute to better clinical management of these diseases in humans.

Przegląd badań

Status

Nieznany

Szczegółowy opis

The significance of epigenetic alterations in autoimmune rheumatic diseases and degenerated joint diseases has drawn great attention among clinicians and researchers. Aberrant methylation status has been demonstrated in human chronic inflammation yet more efforts have focused on global and sequence-specific hypomethylation and overexpression of specific genes. Few studies investigated the regulation of S-adenosylmethionine homeostasis and regulation during inflammation. At present the relevance and regulation of the complex epigenetic profiles and their modifications among different tissues and organs during inflammation remain largely unknown.

Typ studiów

Obserwacyjny

Zapisy (Oczekiwany)

250

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat do 80 lat (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Metoda próbkowania

Próbka prawdopodobieństwa

Badana populacja

patients with arthritis or healthy adults

Opis

Inclusion Criteria:

  • > 18 years

Exclusion Criteria:

  • pregnancy,
  • anemia (hemoglobin 10 mg/dL or lower),
  • thrombocytopenia (platelet count below 50,000 cells/μL),
  • abnormal serum hepatic transaminase (aspartate aminotransferase or alanine aminotransferase above 50 IU/L),
  • diabetes or cancer

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Kohorty i interwencje

Grupa / Kohorta
Arthritis
subjects with arthritis
Health control subjects
Health control

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
s-adenosylmethionine
Ramy czasowe: Blood were collected at admission. Some participants were followed for 4wks if medication was changed by the doctor
blood samples were collected and stored for later analyses of above metabolites
Blood were collected at admission. Some participants were followed for 4wks if medication was changed by the doctor
homocysteine
Ramy czasowe: Blood were collected at admission. Some participants were followed for 4wks if medication was changed by the doctor
blood samples were collected and stored for later analyses of above metabolites
Blood were collected at admission. Some participants were followed for 4wks if medication was changed by the doctor
folate
Ramy czasowe: Blood were collected at admission. Some participants were followed for 4wks if medication was changed by the doctor
blood samples were collected and stored for later analyses of above metabolites
Blood were collected at admission. Some participants were followed for 4wks if medication was changed by the doctor
vitamin B6
Ramy czasowe: Blood were collected at admission. Some participants were followed for 4wks if medication was changed by the doctor
blood samples were collected and stored for later analyses of above metabolites
Blood were collected at admission. Some participants were followed for 4wks if medication was changed by the doctor

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
blood amino acid profile (serine, glycine, methionine,cysteine, cystathionine, dimethylglycine)
Ramy czasowe: Blood were collected at admission. Blood were dawn again 1mo later if his medication was changed by the doctor
blood samples were collected and stored for later analyses of above metabolites
Blood were collected at admission. Blood were dawn again 1mo later if his medication was changed by the doctor
gene expression of target enzymes in PBMCs
Ramy czasowe: Blood were collected at admission.Blood were dawn again 1mo later if his medication was changed by the doctor
blood samples were collected and stored for later analyses
Blood were collected at admission.Blood were dawn again 1mo later if his medication was changed by the doctor
enzyme activities of S-adenosylmethionine synthase in RBC
Ramy czasowe: Blood were collected at admission. Blood were dawn again 1mo later if his medication was changed by the doctor
blood samples were collected and stored for later analyses of above metabolites
Blood were collected at admission. Blood were dawn again 1mo later if his medication was changed by the doctor
vitamin B6 metabolic enzyme in RBC
Ramy czasowe: Blood were collected at admission. Blood were dawn again 1mo later if his medication was changed by the doctor
blood samples were collected and stored for later analyses of above metabolites
Blood were collected at admission. Blood were dawn again 1mo later if his medication was changed by the doctor
polymorphisms in one carbon metabolism enzymes in PBMCs
Ramy czasowe: Blood were collected at admission. Blood were dawn again 1mo later if his medication was changed by the doctor
blood samples were collected and stored for later analyses
Blood were collected at admission. Blood were dawn again 1mo later if his medication was changed by the doctor

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Śledczy

  • Główny śledczy: En-Pei I Chiang, PhD, Department of Food Science and Biotechnology, National Chung Hsing University

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów

1 stycznia 2011

Zakończenie podstawowe (Rzeczywisty)

1 lipca 2014

Ukończenie studiów (Oczekiwany)

1 sierpnia 2015

Daty rejestracji na studia

Pierwszy przesłany

28 lipca 2015

Pierwszy przesłany, który spełnia kryteria kontroli jakości

6 sierpnia 2015

Pierwszy wysłany (Oszacować)

11 sierpnia 2015

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Oszacować)

11 sierpnia 2015

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

6 sierpnia 2015

Ostatnia weryfikacja

1 sierpnia 2015

Więcej informacji

Terminy związane z tym badaniem

Dodatkowe istotne warunki MeSH

Inne numery identyfikacyjne badania

  • SF11093

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj